The trends driving ELRIG Drug Discovery 2022
Drug Discovery World
OCTOBER 4, 2022
BV-101 is an adeno- associated virus (AAV) gene therapy vector that simultaneously addresses the metabolic dysfunction of diseased neurons and contributes to the clearance of the mutant huntingtin protein. The psychedelics medicine market is rising in value, with Data Bridge Market Research predicting it will reach $8 billion by 2029.
130 
Let's personalize your content